BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, April 28, 2026
Home » Topics » Briefs » Appointments and advancements

Appointments and advancements
Appointments and advancements RSS Feed RSS

Appointments and advancements for July 2, 2020

July 2, 2020
New hires and promotions in the biopharma industry, including: Dalcor, Harpoon, JSC Olainfarm, Lodo, Novavax, Noxxon, NuGenerex, Rexgenero, Theravance.
Read More

Appointments and advancements for July 1, 2020

July 1, 2020
New hires and promotions in the med-tech industry, including: Biosig Technologies, Edap Tms, Hallura, Mentice, Sharps Compliance.
Read More

Appointments and advancements for July 1, 2020

July 1, 2020
New hires and promotions in the biopharma industry, including: 4Bio, Akari, Arcturus, Beigene, Cellectar, Codiak, Egenesis, Khondrion, Moderna, Scenic, Sotio, Trevi, Xoma, Zentalis.
Read More

Appointments and advancements for June 30, 2020

June 30, 2020
New hires and promotions in the med-tech industry, including: Daxor, Sarepta Therapeutics, Siren Care, Subiomed.
Read More

Appointments and advancements for June 30, 2020

June 30, 2020
New hires and promotions in the biopharma industry, including: Arvinas, Avrobio, Cara, Evaxion, Leo, Mereo.
Read More

Appointments and advancements for June 29, 2020

June 29, 2020
New hires and promotions in the med-tech industry, including: Cergentis, Enchroma, Medcura.
Read More

Appointments and advancements for June 29, 2020

June 29, 2020
New hires and promotions in the biopharma industry, including: Adverum, Akcea, AM-Pharma, Novavax, PDC*Line.
Read More

Appointments and advancements for June 26, 2020

June 26, 2020
New hires and promotions in the med-tech industry, including: Cardinal Health, Neuronetics, Sera Prognostics.
Read More

Appointments and advancements for June 25, 2020

June 25, 2020
New hires and promotions in the med-tech industry, including: CHF Solutions, Median Technologies, Sight Sciences, Titan Medical.
Read More

Appointments and advancements for June 24, 2020

June 24, 2020
New hires and promotions in the med-tech industry, including: Clarify Medical, Dih, Fast Biomedical, Sera Prognostics.
Read More
Previous 1 2 … 285 286 287 288 289 290 291 292 293 … 322 323 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 27, 2026.
  • Illustration of a tumor

    Detecting the invisible: minimal residual disease at AACR 2026

    BioWorld Science
    Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
  • Boy cupping ear with soundwave graphic

    A free gene therapy? Regeneron’s Otarmeni approved for hearing loss

    BioWorld
    Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
  • Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists

    BioWorld Science
    Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
  • Glowing neural network inside a transparent capsule surrounded by a large language model

    Pharma industry faces long haul to get return on investment from AI

    BioWorld Science
    Artificial intelligence tools are springing up at multiple points along drug discovery and development, but despite the hype, as yet there is minimal return on...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing